Sartorius Collaborates with Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification

Overview

The life science group Sartorius is collaborating with biopharmaceutical company Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing. Selected as a preferred supplier, Sartorius will contribute its engineering and manufacturing expertise to commercialize ICB platforms based on prototypes developed by Sanofi. In return, Sanofi will grant Sartorius exclusive access to its know-how and patents related to the ICB platform.

Post Agreement

• Sartorius is committing to the rapid development of hardware, consumables and process automation for diverse applications and volumes from development to commercial scale. 
•  As part of the collaboration and license agreement, Sartorius will exclusively commercialize the ICB platform offering to customers worldwide.

From Sartorius

“Technological innovation is crucial for biopharmaceutical companies to significantly reduce the cost of drug manufacturing - while improving the environmental footprint of their operations – and ultimately getting life-saving drugs to patients faster. As the biologics landscape becomes more diverse, teaming up with Sanofi is an excellent basis for developing a unique modular platform that combines flexibility with the advantages of intensified bioprocessing. This collaboration will help Sartorius to further expand its position as a leading company in the field of integrated and continuous bioprocessing,” said Jan Schäfer, Head of Separation Systems at Sartorius.

Integrated Continuous Biomanufacturing

• Integrated continuous biomanufacturing is an advanced approach to the production of biopharmaceuticals. 
• The concept aims to maximize efficiency by enabling uninterrupted and steady materials flow, as opposed to traditional batch methods, and by integrating multiple unit operations into a lean process setup. 
• ICB reduces the overall process footprint, leading to lower raw material and energy consumption, higher productivity, and less waste.

What Sartorius Offers

• Sartorius offers a wide array of applications for process intensification in both upstream and downstream, ranging from high-throughput tools for process development to scalable, flexible manufacturing solutions.
• Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification

About Sartorius

• Sartorius is a leading international partner of life sciences research and the biopharmaceutical industry. 
• With innovative laboratory instruments and consumables, the Group’s Lab Products & Services division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!